CIHR — Other: One Health Antimicrobial Resistance Research Network

Description

Antimicrobials play a critical role in human health, animal health, agriculture and food production, and drug-resistant microorganisms can spread between species and environments, exacerbating antimicrobial resistance (AMR). In humans, AMR impacts treatment for infections, including sepsis, and was responsible for 1.27 million deaths globally in 2019.¹

To address the interconnectedness of AMR and antimicrobial use (AMU) across sectors, a One Health approach that considers the interconnectedness of human, animal, plant and environmental health is embedded within the ten priority actions and desired outcomes described in the Pan-Canadian Action Plan on AMR (PCAP). One of the priority actions is the development of a National One Health AMR Research Strategy.

The Canadian Institutes of Health Research (CIHR) and Agriculture and Agri-Food Canada (AAFC) — with strategic and scientific leadership from the CIHR Institute of Infection and Immunity (III), and in collaboration with the Public Health Agency of Canada (PHAC) and Environment and Climate Change Canada (ECCC) — are co-leading the development of this strategy. It will aim to establish national AMR research priorities that address gaps in knowledge across PCAP actions, strengthen collaboration and support future research investments.

To complement these efforts, the CIHR AMR Research Initiative will provide funding to support a One Health AMR Research Network. This funding opportunity builds on existing investments in the AMR research ecosystem, including a Summer 2025 Planning and Dissemination Grants competition to Strengthen Canada’s AMR Research Community Through New Partnerships, Coordination and Knowledge Exchange Across One Health Sectors and a multi-year, cross-regional, intersectoral investment in the One Health AMR Health Research Training Platform (HRTP).

This funding opportunity will provide multi-year funding to support a multi-sectoral, interdisciplinary network that will generate coordinated, timely and One Health-oriented research on AMR aligned with the PCAP, the forthcoming national strategy and self-identified research priorities of Indigenous Peoples (First Nations, Inuit and Métis). The network is also expected to advance Canada’s leadership in One Health AMR research through international partnerships and align with global AMR and One Health initiatives. As a CIHR-funded network, it will generate research and knowledge mobilization outputs to directly benefit the health of people in Canada.

Funding Value

The total amount available for this funding opportunity is $5,600,000, enough to fund approximately one grant. This amount may increase if additional funding partners participate. The maximum amount for this grant is up to $1,000,000 per year for five years. An additional $600,000 is available in the first year of funding (2026-27) to support priority activities relevant to the National One Health AMR Research Strategy.

Eligibility Criteria

Visit CIHR — Other: One Health Antimicrobial Resistance Research Network on the ResearchNet website for details on eligibility.

Sponsor’s Website

CIHR — Other: One Health Antimicrobial Resistance Research Network

Internal Contacts

Faculty Research Facilitator

Deadlines

Submitting Your Application

1. Log in to cuResearch and submit an internal Carleton Approval Form. Consult the cuResearch user’s manual for guidance.
2. Submit an external application to CIHR by following their submission guidelines.